The role of a specialized hospital in the treatment of testicular germ cell tumors (literature review, case studies)
Eldar M. Mamizhev,
Eldar E. Topuzov,
Rashida V. Orlova,
Zarema A. Tambieva,
Vadim G. Pishchik,
Diana I. Rumyantseva,
Pavel M. Gorlin,
Alexander K. Nosov https://doi.org/10.62546/3034-1477-2025-3-4-19-26
Abstract
Achieving remission in testicular germ cell tumors with 5-year survival rates of up to 99% [1, 2] has become possible due to a systemic approach that includes both surgical treatment and systemic platinum-based therapy. However, the low incidence of this pathology in regional medical and preventive institutions, the lack of visibility in the practice of many doctors lead to a delay in diagnosis and lack of quality treatment that meets all the standards of clinical recommendations of the Russian Federation. Untimely treatment by a specialist, diagnostic errors and non-compliance with the standards of medical care in patients with testicular germ cell tumors inevitably reduce survival and worsen the results of subsequent treatment. The aim of the study is to analyze the role of a specialized oncology hospital and a multidisciplinary tumor board in optimizing the diagnosis and treatment of patients with testicular germ cell tumors based on literature data and our own clinical observations.
About the Authors
Eldar M. Mamizhev
City Clinical Oncology Dispensary
Russian Federation
Russian Federation
St. Petersburg.
Eldar E. Topuzov
City Clinical Oncology Dispensary
Russian Federation
Russian Federation
St. Petersburg.
Rashida V. Orlova
City Clinical Oncology Dispensary
Russian Federation
Russian Federation
St. Petersburg.
Zarema A. Tambieva
North Caucasus State Academy
Russian Federation
Russian Federation
Cherkessk, Karachay-Cherkess Republic.
Vadim G. Pishchik
City Clinical Oncology Dispensary
Russian Federation
Russian Federation
St. Petersburg.
Diana I. Rumyantseva
St. Petersburg State University
Russian Federation
Russian Federation
St. Petersburg.
Pavel M. Gorlin
N. N. Petrov National Medical Research Centre of Oncology
Russian Federation
Russian Federation
St. Petersburg.
Alexander K. Nosov
N. N. Petrov National Medical Research Centre of Oncology
Russian Federation
Russian Federation
St. Petersburg.
References
1. Patrikidou A. et al. European Association of Urology Guidelines on Testicular Cancer: 2023 Update // European urology . 2023. Vol. 84, No. 3. Р. 289–301. doi: 10.1016/j.eururo.2023.04.010.
2. Giannatempo P. et al. Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomes // Annals of oncology: official journal of the European Society for Medical Oncology . 2015. Vol. 26, No. 4. Р. 657–668. doi: 10.1093/annonc/mdu447.
3. Злокачественные новообразования в России в 2024 году (заболеваемость) / под ред. А. Д. Каприна и др. Москва: МНИОИ им. П. А. Герцена филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2025. 178 с.
4. Ries L.G., Kosary C.L., Hankey B.F., Miller B.A., Edwards B.K., eds. SEER cancer statistics review 1973–1995. Bethesda, Md.: U.S. Dept of Health and Human Services, Public Health Institute, National Institutes of Health, 1998.
5. Vorobyev A.V., Nosov A.K. Diagnosis of testicular germ cell tumors, staging, and prognostic factors. Practical Oncology , 2006, Vol. 7, No. 1, рр. 10–12 (In Russ.).
6. Huyghe E. et al. Impact of diagnostic delay in testis cancer: results of a large population-based study // European urology . 2007. Vol. 52, No. 6. Р. 1710–1716. doi: 10.1016/j.eururo.2007.06.003.
7. Bosl G.J. et al. Impact of delay in diagnosis on clinical stage of testicular cancer // Lancet (London, England). 1981. Vol. 2, No. 8253. Р. 970–973. doi: 10.1016/s0140-6736(81)91165-x.
8. Ware S.M. et al. Testicular germ cell tumors. Prognostic factors // Urology . 1980. Vol. 15, No. 4. Р. 348–352. doi: 10.1016/0090-4295(80)90467-7.
9. Dieckmann K.-P. Diagnostic delay in testicular cancer: an analytic chimaera or a worthy goal? // European urology. 2007. Vol. 52, No. 6. Р. 1566–1568. doi: 10.1016/j.eururo.2007.06.035.
10. Nosov A.K., Mamizhev E.M., Reva S.A. et al. Impact of delayed prehospital diagnosis on the results of treatment in patients with germinogenic testicular tumors in St. Petersburg. Cancer Urology , 2013, Vol. 9, No. 2, рр. 63–68 (In Russ.). https://doi.org/10.17650/1726-9776-2013-9-2-63-68.
11. Amat N. et al. The impact of uro-oncology multidisciplinary team meeting (MDTM) on clinical decision-making and adherence to MDTM recommendation: experience from a tertiary referral centre in Malaysia // African Journal of Urology . 2024. Vol. 30, No. 1. Р. 12. https://doi.org/10.1186/s12301-024-00415-4
12. Santoso J.T. et al. Tumor board in gynecologic oncology // International journal of gynecological cancer: official journal of the International Gynecological Cancer Society . 2004. Vol. 14, No. 2. Р. 206–209. doi: 10.1111/j.1048891X.2004.014200.x.
13. Greer H.O. et al. Impact of a weekly multidisciplinary tumor board conference on the management of women with gynecologic malignancies // International journal of gynecological cancer: official journal of the International Gynecological Cancer Society . 2010. Vol. 20, No. 8. Р. 1321–1325. doi: 10.1111/IGC.0b013e3181f5871e.
14. Newman E.A. et al. Changes in surgical management resulting from case review at a breast cancer multidisciplinary tumor board // Cancer . 2006. Vol. 107, No. 10. Р. 2346–2351. doi: 10.1002/cncr.22266.
15. De Ieso P.B. et al. A study of the decision outcomes and financial costs of multidisciplinary team meetings (MDMs) in oncology // British journal of cancer . 2013. Vol. 109, No. 9. Р. 2295–2300. doi: 10.1038/bjc.2013.586.
16. Cohen P. et al. The multidisciplinary tumor conference in gynecologic oncology does it alter management? // International journal of gynecological cancer: official journal of the International Gynecological Cancer Society . 2009. Vol. 19, No. 9. Р. 1470–1472. doi: 10.1111/IGC.0b013e3181bf82df.
17. Taggar A.S. et al. Exposure to radiation and medical oncology training: A survey of Canadian urology residents and fellows // Canadian Urological Association journal = Journal de l’Association des urologues du Canada . 2018. Vol. 12, No. 10. Р. 321–325. doi: 10.5489/cuaj.5147.
18. Betschart P. et al. Shared Decision-Making for Patients with Advanced Urological Malignancies: Evaluation of a Joint Urological-Oncological Clinic Model // Oncology research and treatment . 2019. Vol. 42, No. 7–8. Р. 366–374. doi: 10.1159/000499721.
19. Rao K. et al. Uro-oncology multidisciplinary meetings at an Australian tertiary referral centre-impact on clinical decision-making and implications for patient inclusion // BJU international . 2014. Vol. 114, Suppl. 1. Р. 50–54. doi: 10.1111/bju.12764.
20. Zhu Sh. et al. Dynamic multidisciplinary team discussions can improve the prognosis of metastatic castration-resistant prostate cancer patients // The Prostate . 2021. Vol. 81, No. 11, Р. 721–727. doi: 10.1002/pros.24167.
21. Harzstark A.L. et al. Implementation of a Multidisciplinary Expert Testicular Cancer Tumor Board Across a Large Integrated Healthcare Delivery System Via Early Case Ascertainment // JCO clinical cancer informatics . 2021. Vol. 5. Р. 187–193. doi: 10.1200/CCI.20.00114.
Review
For citations:
Mamizhev E.M., Topuzov E.E., Orlova R.V., Tambieva Z.A., Pishchik V.G., Rumyantseva D.I., Gorlin P.M., Nosov A.K. The role of a specialized hospital in the treatment of testicular germ cell tumors (literature review, case studies). Clinical Case in Oncology. 2025;3(4):19-26. (In Russ.) https://doi.org/10.62546/3034-1477-2025-3-4-19-26
Views:
9
JATS XML
Email this article 